Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Hadas, Smadar ^a   Spira, Maya ^a,b   Hanisch, Uwe Karsten ^c   Reichert, Fanny ^a   Rotshenker, Shlomo ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cofilin; Complement receptor 3; Macrophage; Microglia; Myelin; Phagocytosis; Syk

Indexed keywords

COFILIN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; F ACTIN; PROTEIN KINASE SYK; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PHAGOCYTOSIS; CONTROLLED STUDY; DOWN REGULATION; FILOPODIUM; MACROPHAGE; MICROGLIA; MOUSE; MYELIN SHEATH; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

EID: 84863511515     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-166     Document Type: Article

References (40)

1. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, observations of the alterations produced thereby in the structure of their primitive fibers. Phil Transact Royal Soc London 1850, 140:423-429.
2. Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow?. Annu Rev Neurosci 2007, 30:153-179. 10.1146/annurev.neuro.30.051606.094354, 17506644.
3. Rotshenker S. Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflammation 2011, 8:109. 10.1186/1742-2094-8-109, 3179447, 21878125.
4. Gao Z, Tsirka SE. Animal models of ms reveal multiple roles of microglia in disease pathogenesis. Neurol Res Int 2011, 201(1):383087.
5. David S, Aguayo AJ. Axonal elongation into peripheral nervous system bridges" after central nervous system injury in adult rats. Science 1981, 214:931-933. 10.1126/science.6171034, 6171034.
6. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006, 7:617-627. 2693386, 16858390.
7. Cao Z, Gao Y, Deng K, Williams G, Doherty P, Walsh FS. Receptors for myelin inhibitors: Structures and therapeutic opportunities. Mol Cell Neurosci 2010, 43:1-14. 10.1016/j.mcn.2009.07.008, 19619659.
8. Kotter MR, Li WW, Zhao C, Franklin RJM. Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation. J Neurosci 2006, 26:328-332. 10.1523/JNEUROSCI.2615-05.2006, 16399703.
9. Silverman BA, Carney DF, Johnston CA, Vanguri P, Shin ML. Isolation of membrane attack complex of complement from myelin membranes treated with serum complement. J Neurochem 1984, 42:1024-1029. 10.1111/j.1471-4159.1984.tb12706.x, 6699635.
10. Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol 2002, 168:458-465.
11. Smith ME. Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE. Microsc Res Tech 2001, 54:81-94. 10.1002/jemt.1123, 11455615.
12. Reichert F, Slobodov U, Makranz C, Rotshenker S. Modulation (inhibition and augmentation) of complement receptor-3- mediated myelin phagocytosis. Neurobiol Dis 2001, 8:504-512. 10.1006/nbdi.2001.0383, 11442357.
13. Reichert F, Rotshenker S. Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages. Neurobiol Dis 2003, 12:65-72. 10.1016/S0969-9961(02)00008-6, 12609490.
14. Rotshenker S. Microglia and macrophage activation and the regulation of complement-receptor-3 (cr3/mac-1)-mediated myelin phagocytosis in injury and disease. J Mol Neurosci 2003, 21:65-72. 10.1385/JMN:21:1:65, 14500997.
15. Yan SR, Huang M, Berton G. Signaling by adhesion in human neutrophils: activation of the p72syk tyrosine kinase and formation of protein complexes containing p72syk and Src family kinases in neutrophils spreading over fibrinogen. J Immunol 1997, 158:1902-1910.
16. Schymeinsky J, Mocsai A, Walzog B. Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications. Thromb Haemost 2007, 98:262-273.
17. Berton G, Mocsai A, Lowell CA. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol 2005, 26:208-214. 10.1016/j.it.2005.02.002, 15797511.
18. Tohyama Y, Yamamura H. Protein tyrosine kinase, Syk: a key player in phagocytic cells. J Biochem 2009, 145:267-273. 10.1093/jb/mvp001, 19124456.
19. Mocsai A, Ruland J, Tybulewicz VL. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 2010, 10:387-402. 10.1038/nri2765, 20467426.
20. Crowley MT, Costello PS, Fitzer-Attas CJ, Turner M, Meng F, Lowell C, Tybulewicz VL, Defranco AL. A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages. J Exp Med 1997, 186:1027-1039. 10.1084/jem.186.7.1027, 2199061, 9314552.
21. Kiefer F, Brumell J, Al-Alawi N, Latour S, Cheng A, Veillette A, Grinstein S, Pawson T. The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils. Mol Cell Biol 1998, 18:4209-4220. 109005, 9632805.
22. Shi Y, Tohyama Y, Kadono T, He J, Shahjahan Miah SM, Hazama R, Tanaka C, Tohyama K, Yamamura H. Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis. Blood 2006, 107:4554-4562. 10.1182/blood-2005-09-3616, 16449524.
23. Underhill DM, Rossnagle E, Lowell CA, Simmons RM. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 2005, 106:2543-2550. 10.1182/blood-2005-03-1239, 1895265, 15956283.
24. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, Schweighoffer E, Tybulewicz V, Reis S, Gordon S, Brown GD. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 2004, 104:4038-4045. 10.1182/blood-2004-03-1140, 15304394.
25. Vartiainen MK, Mustonen T, Mattila PK, Ojala PJ, Thesleff I, Partanen J, Lappalainen P. The three mouse actin-depolymerizing factor/cofilins evolved to fulfill cell-type-specific requirements for actin dynamics. Mol Biol Cell 2002, 13:183-194. 10.1091/mbc.01-07-0331, 65081, 11809832.
26. Wang W, Eddy R, Condeelis J. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007, 7:429-440. 10.1038/nrc2148, 17522712.
27. Van RJ, Condeelis J, Glogauer M. A common cofilin activity cycle in invasive tumor cells and inflammatory cells. J Cell Sci 2009, 122:305-311. 10.1242/jcs.031146, 2772875, 19158339.
28. Bernstein BW, Bamburg JR. ADF/cofilin: a functional node in cell biology. Trends Cell Biol 2010, 20:187-195. 10.1016/j.tcb.2010.01.001, 2849908, 20133134.
29. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 2009, 10:778-790. 10.1038/nrm2786, 2834236, 19851336.
30. Makranz C, Cohen G, Baron A, Levidor L, Kodama T, Reichert F, Rotshenker S. Phosphatidylinositol 3-kinase, phosphoinositide-specific phospholipase-Cgamma and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 alone and combined with scavenger receptor-AI/II in macrophages. Neurobiol Dis 2004, 15:279-286. 10.1016/j.nbd.2003.11.007, 15006698.
31. Cohen G, Makranz C, Spira M, Kodama T, Reichert F, Rotshenker S. Non-PKC DAG/Phorbol-Ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCgamma activate myelin phagocytosis by both. Glia 2006, 53:538-550. 10.1002/glia.20304, 16374778.
32. Rotshenker S, Reichert F, Gitik M, Haklai R, Elad-Sfadia G, Kloog Y. Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia 2008, 56:1607-1613. 10.1002/glia.20713, 18615637.
33. Rotshenker S. The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J Mol Neurosci 2009, 39:99-103. 10.1007/s12031-009-9186-7, 19253007.
34. Gitik M, Reichert F, Rotshenker S. Cytoskeleton plays a dual role of activation and inhibition in myelin and zymosan phagocytosis by microglia. FASEB J 2010, 24:2211-2221. 10.1096/fj.09-146118, 20179145.
35. Slobodov U, Reichert F, Mirski R, Rotshenker S. Distinct Inflammatory Stimuli Induce Different Patterns of Myelin Phagocytosis and Degradation in Recruited Macrophages. Exp Neurol 2001, 167:401-409. 10.1006/exnr.2000.7559, 11161629.
36. Hadas S, Reichert F, Rotshenker S. Dissimilar and similar functional properties of complement receptor-3 in microglia and macrophages in combating yeast pathogens by phagocytosis. Glia 2010, 58:823-830.
37. Lai JY, Cox PJ, Patel R, Sadiq S, Aldous DJ, Thurairatnam S, et al. Potent small molecule inhibitors of spleen tyrosine kinase (Syk). Bioorg Med Chem Lett 2003, 13:3111-3114. 10.1016/S0960-894X(03)00658-9, 12941345.
38. Lavens-Phillips SE, Mockford EH, Warner JA. The effect of tyrosine kinase inhibitors on IgE-mediated histamine release from human lung mast cells and basophils. Inflamm Res 1998, 47:137-143.
39. Wang BH, Lu ZX, Polya GM. Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol. Planta Med 1998, 64:195-199. 10.1055/s-2006-957407, 9581512.
40. Luskova P, Draber P. Modulation of the Fcepsilon receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr Pharm Des 2004, 10:1727-1737. 10.2174/1381612043384538, 15180535.